glp 1 lawsuits GLP-1 Medications GLP-1 Litigation and the Road
Description
Diabetes Complications 28 , 399405 (2014)
Only one study showed that TC cell lines treated with lobeglitazone in vitro showed a significant reduction of TGF-1-induced EMT-associated processes and EMT markers expression reducing also cell migration and invasion
The new retatrutide study is a phase 3 clinical trialthe gold standard needed to secure eventual FDA approvalcalled TRIUMPH-1
(2019) who investigated the risk of developing IBD in patients on DPP-IV inhibitor therapy point out the need for further research
doi: 10.1111/joim.12580
The decision expands access to Eli Lillys weight-loss portfolio through one of the nations largest pharmacy benefit managers
